Feb 13, 2020
Isotopia Molecular Imaging and Eckert & Ziegler to Start Partnership for Prostate Cancer Imaging
Jan 20, 2020
Polaryx Therapeutics Receives IND Approval for PLX-200 From the FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis
Dec 23, 2019
Polaryx Therapeutics Submits Investigational New Drug Application to the U.S. FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis With PLX-200
Oct 09, 2019
GE Healthcare and Theragnostics Announce Global Commercial Partnership for Late Stage PSMA Diagnostic for Prostate Cancer
Oct 19, 2018
New Data From the MIV-711 Phase II Program Will be Presented at the ACR Annual Meeting on October 21
Sep 21, 2018
The Global Market for Papain (2018-2024) Featuring Aumgene Biosciences, Excellent Biotechnologies, Beckmann-Kenko, AXO Industry, Fruzyme Biotech India, and more - ResearchAndMarkets.com
Sep 19, 2018
Alpha-1 Anti-Trypsin Deficiency Epiomic Epidemiology Forecasts 2018-2028
Sep 18, 2018
Coalition to Cure Calpain 3 Provides Gene Therapy Initiative Updates
Jul 27, 2018
MIV-711 Osteoarthritis Phase IIa Extension Study Outcomes Show Continuing Positive Effect on Joint Structure
Jun 28, 2018
Medivir Announces Positive Top-line Results From the MIV-711 Osteoarthritis Phase IIa Extension Study
Apr 26, 2018
Medivir AB: Data From the MIV-711 Initial Phase IIa Study Will be Presented at the OARSI World Congress on April 27
Feb 26, 2018
Polaryx Therapeutics Received Orphan Drug Designation From the European Medicines Agency (EMA) for the Treatment of Neuronal Ceroid Lipofuscinosis With PLX-200
Feb 06, 2018
WORLDSymposium Recognizes BioMarin's Brineura® (cerliponase alfa) with 2018 New Treatment Award
Dec 11, 2017
Polaryx Therapeutics Receives Orphan Drug Designation From the US FDA for the Treatment of Neuronal Ceroid Lipofuscinoses With PLX-100
Nov 09, 2017
Medivir: MIV-711 Phase IIa Osteoarthritis Study Data Presented as a Late Breaking Poster at the Annual Meeting of the American College for Rheumatology
Nov 09, 2017
Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2017
Oct 18, 2017
Popular Science Names BioMarin's Brineura® (cerliponase alfa) One of the Top Health Innovations of 2017 with "Best of What's New" Award
Aug 31, 2017
Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or PMN Elastase or Human Leukocyte Elastase or ELANE or EC 3.4.21.37) - Pipeline Review, H2 2017
Jun 01, 2017
European Commission Approves Brineura(TM) (cerliponase alfa), the First Treatment for CLN2 Disease, a Form of Batten Disease and Ultra-Rare Brain Disorder in Children
May 11, 2017
Global Proteases Market - Growth, Trends & Forecasts to 2022 - Key Players are Advanced Enzyme, Amano Enzyme, Associated British Foods, Biocatalysts & Chr. Hansen Holdings - Research and Markets